Author: Marie Jones

On June 11th, 2020, DL Holdings (1709.HK) announced a MOU for a significant transaction involving a capital of approximately $40 million HK dollars. According to the announcement, DL Holdings Group Ltd. will invest $5 million US dollars in Carmel Reserve LLC for a 28.5% stake in the company. Carmel Reserve LLC owns 891 acres of land in Carmel Valley which is located at San Francisco Bay Area in California, US. This project, ONE Carmel, planes to develop a premier community with 73 ultra-high-end residential lots. After acquiring securities business and establishing fund investment business, DL Holdings further added real estate…

Read More

After successively obtaining approval from the China Banking and Insurance Regulatory Commission and the China Securities Regulatory Commission, China Pacific Insurance (Group) Co., Ltd. (hereinafter referred to as “China Pacific Insurance”, stock code: SH601601; HK02601) announced on June 10, 2020 that it had issued the Intention to Float (“ITF”) to list Global Depositary Receipts (GDR) on the London Stock Exchange. The issuance of the ITF implies that China Pacific Insurance has received greenlight from both domestic and overseas regulatory authorities for the GDR issuance, and has taken a major step towards listing. Post the completion of the issuance, China Pacific…

Read More

German record label 99 Problemz Music has been giving young newcomer artists a chance to prove their talent with the possibility of getting signed. Currently the Munich label has a total of five artists attached to its brand: Hydra, Fake Rayban, R.S., JBP, and Poldi. With their unique approach, these individuals have decided to take the music industry head on, in order to become the success story that society will hear about. Gangster Hip-Hop music has been around since the mid 80’s, driven by rappers such as Ice-T and N.W.A during that period of time. Today, music has changed and…

Read More

– Group cites UN Brief on Impact of COVID-19 on Food Security & Nutrition as ‘Clarion Call’ for Asia – Raises Need for Greater Coordination, Collaboration across Regional Food Value Chain A policy brief released this week by the United Nations (UN), “The Impact of COVID-19 on Food Security and Nutrition”, raises serious concerns regarding the effect COVID-19 is having on the most vulnerable parts of society already experiencing hunger and malnutrition. As a result, CropLife Asia is reiterating the need for greater coordination and collaboration across the regional food value chain to ensure a sustainable supply of safe and…

Read More

Adelaide, AUS, June 11, 2020 – (ACN Newswire) – Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, encouraged biotechs to consider Australia for their clinical trials during a presentation at BIO Digital 2020. Watch the BIO Digital 2020 presentation here: https://www.bio.org/events/bio-digital/sessions/search?name=Agilex The presentation by CEO Jason Valentine and moderated by VP Business Development Julia Jones details the current trials landscape in Australia and why biotechs wanting to avoid delays caused by COVID-19, can move their trials to Australia. Australia’s impressive COVID-19 management and the world’s most attractive rebate on clinical trials costs are just a few of the reasons that make it…

Read More

Updates include launch of custom-tailored data models with new algorithms to personalize enablement automation at scale. Bigtincan (ASX: BTH), the leader in AI-powered sales enablement automation, today announced its Spring 2020 release. This release adds over 45 new features and capabilities supporting the company’s commitment to intelligent automation and sales readiness 2.0. “The global pandemic has had unexpected downstream effects on consumers and businesses, presenting a unique opportunity for companies to build customer value and trust,” said David Keane, CEO at Bigtincan. “Our vision is to empower sellers with one platform, delivering sales readiness, just in time content, and automated document…

Read More

Development programme creates opportunities in a volatile economy Start-up Express, an entrepreneurship development programme organised by the Hong Kong Trade Development Council (HKTDC), has returned for its third edition. The pitching contest under the programme successfully concluded today as a judging panel selected exceptional start-ups to participate in local and international activities to build connections, explore markets, seek partners and enhance brand awareness. In response to the COVID-19 outbreak, the Pitching Final was livestreamed online with a live polling of the “My Favourite Start-up Award”, which was awarded to MICology. Stephen Liang, Assistant Executive Director of HKTDC said: “Start-ups have been…

Read More

Strengths in technological research and application have helped Hong Kong contain the COVID-19 outbreak and cope with the disruptions it caused. To create business opportunities for local technology enterprises that develop products and services to tackle the pandemic and related areas, the Hong Kong Trade Development Council (HKTDC) is collaborating with the Commerce and Economic Development Bureau (CEDB) and Innovation and Technology Bureau (ITB) of the HKSAR Government to launch a promotion campaign, sharing their experiences with overseas markets and showcasing the technologies to economies abroad. HKTDC Chairman Dr Peter K N Lam said: “The world is working…

Read More

Colenso BBDO wins Grand Prix and Best Multiplatform Award for DB Export campaign I’m Drinking It For You Campaigns for DB Export in New Zealand, Century 21 in the US, Mastercard in India, McDonald’s in China and Al Tayer Motors in the UAE, are among the winners of the Effective Content Strategy category of the WARC Awards, a global search for next-generation marketing effectiveness. A total of 13 campaigns – one Grand Prix, three Golds, five Silvers and four Bronzes – have won in the Effective Content Strategy category, which rewards content strategies that can demonstrate a business outcome. Colenso BBDO…

Read More

Mohammad Reza Goodary, known as Reza (the Persian Leopard) Goodary, was born on December 14th, 1988 in Tehran to a noble family. Due to childhood hyperactivity, his father took him to practice Judo. June 24th, 1995 was his first day in a dojo (martial arts gym) and the day the world opened the window of martial arts for him. When asked what he remembers about that day, he says, “I don’t remember much. I just know I never thought I would be motivated enough to practice and fight after 25 years.” It wasn’t long before he was introduced to Kung-Fu…

Read More

The new plan is part of AppsFlyer’s zero budget marketing initiative, consolidating products and tools enabling developers, product managers, and marketers to uncover the potential of their core assets AppsFlyer, the global attribution leader, today announced the launch of Zero, a free-for-life package as part of its Zero Budget Marketing initiative. The new initiative, geared towards developers, product managers, and marketers offers free, state of the art software tools and APIs, to empower their growth and leverage their earned and owned media strategy. As part of AppsFlyer’s effort to enable companies of any size to better utilize their owned assets…

Read More

Black Spade Capital Limited (“Black Spade Capital”), a family office managing the private investments of Mr. Lawrence Ho, Chairman and Chief Executive of Melco International Development Limited, has announced it has invested and held shares in My Platform, a medical IT services platform. Founded in Hong Kong as a start-up, My Platform was launched as a brand-new medical management system by marrying IT with the concept of smart medical care. The result is a one-stop resources sharing platform with real-time access that connects the many stakeholders in the traditional healthcare ecosystem. The enormous growth potential of My Platform has attracted…

Read More

澳大利亞領先的生物科技合同研究組織Avance Clinical在今天的生物科技創新組織數字會議上宣布,目前,澳大利亞共有2413個計劃或在行測試項目。在澳大利亞,雖然新冠疫情肆虐,健康志願研究並未中止,只有27個一期或二期研究項目因各種原因暫停(TrialTrove,2020年6月9日)。 Avance Clinical高度讚揚澳大利亞工業界出色的新冠疫情管理能力,這就意味著,澳大利亞在維持臨床測試業務方面引領全球。 Avance Clinical首席戰略官Ben Edwards在2020年生物科技創新組織數字會議上介紹了澳大利亞臨床測試工作的諸多好處。 點擊下方鏈接,查看Avance Clinical生物科技創新組織數字會議演講稿。 https://www.bio.org/events/bio-digital/sessions/search?name=Avance%20Clinical Edwards先生講:“大約96%的工作支持中小型生物科技公司,執行一期和二期測試項目。我們的客戶遍及北美洲、加拿大、新西蘭、歐洲和亞洲。 澳大利亞在國際臨床測試方面具有無以倫比的優勢。我們對新冠疫情的管理是澳大利亞成為了臨床測試最佳目的地。 ” Avance Clinical是一家以靈活協作的方法聞名的中型全方位服務CRO,在管理早期試驗方面擁有20多年的經驗。 除了出色的新冠疫情管理能力,另一個重要因素就是速度、高質量場地和運營測試項目成本誘人。 – 澳大利亞政府對臨床試驗支出提供的43.5%以上的財政退款 – 臨床試驗無需IND,簡化監管流程 – 先進的醫療、研究和科學團體,領先的調查人員和KOL,以及現代化的醫療設施 觀看視頻-我們如何在新冠疫情肆虐的環境下開展工作。 https://tinyurl.com/yc2z6kjj 澳大利亞因其在FDA標準的科學合規性和研究卓越性、醫療保健先進性,以及有機會在臨床試驗競爭較少的環境中接觸患者等方面的優勢而享有盛譽聲譽,這也進一步增強了其作為臨床試驗目的地的優勢。 想了解更多關於在澳大利亞開展您下一項研究的優勢,請聯繫我們: https://www.avancecro.com/contact-us/ 關於 Avance Clinical Avance Clinical擁有20多年的從業經驗,目前是澳大利亞領先的合同研究機構之一。 Avance Clinical通過協調人員、技能和專業知識,促進高質量的藥物開發,以追求更健康的世界。 AvanceClinical憑藉其經驗豐富的團隊,致力於提供高質量的臨床研究服務。 Avance Clinical的知識和經驗庫也得益於精心挑選的專家在不斷地擴張,這些專家也表現出對所選領域的高度熱情。 Avance Clinical在成熟的臨床試驗生態系統中提供高質量的服務,包括世界級的研究人員和能夠訪問特定患者組群的中心。其他好處還包括: 1. 政府發放研發經費,意味著可享受超過43.5%的臨床試驗經費返利。 2. 遠程醫療在COVID-19大流行期間的樞紐作用——快速和連續性。 3. 網上問診(SIV)和研究的啟動在 5 — 6週得以實現。 4. 臨床試驗不需要IND申報。 5. 一期臨床試驗不要求使用完整的GMP材料。 6. 建立了具有世界一流的研究人員和場所的臨床試驗環境。 7. 建立健康的受試者數據庫和專業的患者群體庫。 8. 整個澳大利亞一期設施分為5個獨立部分,其中包括以醫院為基礎的重症監護室。 9. 擁有世界一流的基礎設施和專業的臨床試驗室的大型醫院,其在FDA合規研究方面有著長期的跟踪記錄 10. 季節性研究:北半球的讚助商可以利用澳大利亞的反流感和季節性過敏進行全年的研究 媒體聯絡: media@avanceCRO.com Chris Thompson

Read More

澳大利亚领先的生物科技合同研究组织Avance Clinical在今天的生物科技创新组织数字会议上宣布,目前,澳大利亚共有2413个计划或在行测试项目。在澳大利亚,虽然新冠疫情肆虐,健康志愿研究并未中止,只有27个一期或二期研究项目因各种原因暂停(TrialTrove,2020年6月9日)。 Avance Clinical高度赞扬澳大利亚工业界出色的新冠疫情管理能力,这就意味着,澳大利亚在维持临床测试业务方面引领全球。 Avance Clinical首席战略官Ben Edwards在2020年生物科技创新组织数字会议上介绍了澳大利亚临床测试工作的诸多好处。 点击下方链接,查看Avance Clinical生物科技创新组织数字会议演讲稿。 https://www.bio.org/events/bio-digital/sessions/search?name=Avance%20Clinical Edwards先生讲:“大约96%的工作支持中小型生物科技公司,执行一期和二期测试项目。我们的客户遍及北美洲、加拿大、新西兰、欧洲和亚洲。 澳大利亚在国际临床测试方面具有无以伦比的优势。我们对新冠疫情的管理是澳大利亚成为了临床测试最佳目的地。” Avance Clinical是一家以灵活协作的方法闻名的中型全方位服务CRO,在管理早期试验方面拥有20多年的经验。 除了出色的新冠疫情管理能力,另一个重要因素就是速度、高质量场地和运营测试项目成本诱人。 – 澳大利亚政府对临床试验支出提供的43.5%以上的财政退款 – 临床试验无需IND,简化监管流程 – 先进的医疗、研究和科学团体,领先的调查人员和KOL,以及现代化的医疗设施 观看视频-我们如何在新冠疫情肆虐的环境下开展工作。https://tinyurl.com/yc2z6kjj 澳大利亚因其在FDA标准的科学合规性和研究卓越性、医疗保健先进性,以及有机会在临床试验竞争较少的环境中接触患者等方面的优势而享有盛誉声誉,这也进一步增强了其作为临床试验目的地的优势。 想了解更多关于在澳大利亚开展您下一项研究的优势,请联系我们: https://www.avancecro.com/contact-us/ 关于 Avance Clinical Avance Clinical拥有20多年的从业经验,目前是澳大利亚领先的合同研究机构之一。 Avance Clinical通过协调人员、技能和专业知识,促进高质量的药物开发,以追求更健康的世界。 AvanceClinical凭借其经验丰富的团队,致力于提供高质量的临床研究服务。Avance Clinical的知识和经验库也得益于精心挑选的专家在不断地扩张,这些专家也表现出对所选领域的高度热情。 Avance Clinical在成熟的临床试验生态系统中提供高质量的服务,包括世界级的研究人员和能够访问特定患者组群的中心。其他好处还包括: 1. 政府发放研发经费,意味着可享受超过43.5%的临床试验经费返利。 2. 远程医疗在COVID-19大流行期间的枢纽作用——快速和连续性。 3. 网上问诊(SIV)和研究的启动在 5 — 6周得以实现。 4. 临床试验不需要IND申报。 5. 一期临床试验不要求使用完整的GMP材料。 6. 建立了具有世界一流的研究人员和场所的临床试验环境。 7. 建立健康的受试者数据库和专业的患者群体库。 8. 整个澳大利亚一期设施分为5个独立部分,其中包括以医院为基础的重症监护室。 9. 拥有世界一流的基础设施和专业的临床试验室的大型医院,其在FDA合规研究方面有着长期的跟踪记录 10. 季节性研究:北半球的赞助商可以利用澳大利亚的反流感和季节性过敏进行全年的研究 媒体联络: media@avanceCRO.com Chris Thompson

Read More

Pipeline of Drug Candidates Has Vast Potential in the Future SinoMab BioScience Limited (“SinoMab” or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, made an oral presentation titled “Efficacy and safety of SM03, a Recombinant Anti-human CD22 Monoclonal Antibody in Chinese Patients with Rheumatoid Arthritis: A Phase II randomized, double-blind, multi-dose, placebo-controlled study” in the evening on 5th June, 2020 at the European League Against Rheumatology (“EULAR”) 2020 Congress(the “Congress”). Professor Zhang Fengchun, the head of Internal Medicine Department of Peking Union…

Read More

Tiger Trade is a mobile and web trading app launched by global online stock brokerage Tiger Brokers. Tiger Trade’s investors and backers include Interactive Brokers such as Barron’s top online brokerage company, Xiaomi, a Chinese tech giant, and Jim Rogers, a Wall Street investment guru. Buoyed by a 345 per cent increase in trading volumes among Singapore-based retail investors during COVID-19, Tiger Trade has launched its in-app SGX functionality. Its easy-to-use mobile app and desktop platform allows retail investors to access even more trading opportunities including the SGX and other global market. Tiger Trade, a one-stop mobile and online trading…

Read More

The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital today that Australia currently has 2,413 trials planned or ongoing. Importantly in Australia, despite the global COVID-19 pandemic, no healthy volunteer studies have been suspended, and only 27 Phase 1 or 2 studies were temporarily put on hold for various reasons (TrialTrove, 9 June 2020). Avance Clinical commended the Australian industry for exceptional COVID-19 management which has meant Australia leads the world in maintaining clinical trials business as usual. Avance Clinical’s Chief Strategy Officer, Ben Edwards presented at BIO Digital 2020 today on the many benefits of running…

Read More

With the worldwide spread of the Novel Coronavirus (COVID-19), orders for Korean diagnostic kits continue to roll in. As part of the effort to combat COVID-19, Joonghun Pharmaceutical announced that it was accelerating efforts to provide its JD COVID-19 qRT-PCR Kit for in vitro diagnostics internationally. The JD COVID-19 qRT-PCR Kit uses Real-time RT-PCR (Real-time Reverse Transcription-Polymerase Chain Reaction), currently the main testing method for detecting SARS-CoV-2 virus in COVID-19, because of its excellent sensitivity and specificity. Joonghun Pharmaceutical’s diagnostic qRT-PCR Kit targets a single gene (N gene) of the coronavirus, based on the FDA and CDC response to COVID-19.…

Read More

INDIA, June 8, 2020 – (JCN Newswire) – The COVID-19 pandemic is being battled across the world. The businesses and organizations have come to an ambiguous halt. In such uncertain times, businesses are reorienting their approach towards the new normal. Especially, for an industry like Events and Conferences, where the real essence is a large gathering of like-minded people which enables the creation of one of experience. Adapting to the new norm, Clavent is organizing a virtual conference on 25th and 26th June 2020 named the “EMERGE 2020 HR TECH SUMMIT”, in which they will be trying to recreate all those elements of an…

Read More

By Geoffrey Weli-Wosu, co-founder of Voguepay.com, an online payment processing company, and founder of Domineum.io, a blockchain technology company. Since the adoption of the Payment Services Directive 2 (PSD2) in 2015 by the EU, there has been a movement towards open banking with UK, European and Asian banks adopting the open data initiative. Open banking implies free access to customers’ personal data through an Application Programming Interface (API). This access can facilitate automatization of payments and verification of credit worthiness as an example. On the one hand, open banking has a number of advantages such as it facilitates competition and fair…

Read More